1. Home
  2. KGS vs IBRX Comparison

KGS vs IBRX Comparison

Compare KGS & IBRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • KGS
  • IBRX
  • Stock Information
  • Founded
  • KGS 2011
  • IBRX 2014
  • Country
  • KGS United States
  • IBRX United States
  • Employees
  • KGS N/A
  • IBRX N/A
  • Industry
  • KGS
  • IBRX Biotechnology: Biological Products (No Diagnostic Substances)
  • Sector
  • KGS
  • IBRX Health Care
  • Exchange
  • KGS Nasdaq
  • IBRX Nasdaq
  • Market Cap
  • KGS 2.6B
  • IBRX 2.4B
  • IPO Year
  • KGS 2023
  • IBRX N/A
  • Fundamental
  • Price
  • KGS $41.12
  • IBRX $2.83
  • Analyst Decision
  • KGS Strong Buy
  • IBRX Buy
  • Analyst Count
  • KGS 11
  • IBRX 2
  • Target Price
  • KGS $37.09
  • IBRX $17.38
  • AVG Volume (30 Days)
  • KGS 834.0K
  • IBRX 5.6M
  • Earning Date
  • KGS 11-06-2024
  • IBRX 11-12-2024
  • Dividend Yield
  • KGS 3.95%
  • IBRX N/A
  • EPS Growth
  • KGS N/A
  • IBRX N/A
  • EPS
  • KGS 0.26
  • IBRX N/A
  • Revenue
  • KGS $1,075,772,000.00
  • IBRX $7,332,000.00
  • Revenue This Year
  • KGS $38.17
  • IBRX $2,572.99
  • Revenue Next Year
  • KGS $15.83
  • IBRX $747.59
  • P/E Ratio
  • KGS $158.31
  • IBRX N/A
  • Revenue Growth
  • KGS 33.77
  • IBRX 1218.71
  • 52 Week Low
  • KGS $19.17
  • IBRX $2.82
  • 52 Week High
  • KGS $44.20
  • IBRX $10.53
  • Technical
  • Relative Strength Index (RSI)
  • KGS 60.09
  • IBRX 29.51
  • Support Level
  • KGS $40.27
  • IBRX $2.82
  • Resistance Level
  • KGS $41.90
  • IBRX $3.18
  • Average True Range (ATR)
  • KGS 1.18
  • IBRX 0.30
  • MACD
  • KGS -0.28
  • IBRX -0.25
  • Stochastic Oscillator
  • KGS 34.02
  • IBRX 0.62

About KGS Kodiak Gas Services Inc.

Kodiak Gas Services Inc is an operator of contract compression infrastructure in the United States. It manages business through two operating segments namely Compression Operations and Other Services. Compression Operations consist of operating company-owned and customer-owned compression infrastructure for customers, pursuant to fixed-revenue contracts to enable the production, gathering and transportation of natural gas and oil. Other Services consist of a full range of contract services to support the needs of customers, including station construction, maintenance and overhaul and other ancillary time and material-based offerings.

About IBRX ImmunityBio Inc.

ImmunityBio Inc is an integrated clinical-stage biotechnology company discovering, developing, and commercializing next-generation immuno- and cellular therapies that bolster the natural immune system to drive and sustain an immune response. Its platforms for the development of biologic product candidates include (i) antibody-cytokine fusion proteins, (ii) DNA, RNA, and recombinant protein vaccines, and (iii) cell therapies. Its focus includes bladder, lung, and colorectal cancers and GBM and its product candidate Anktiva is an IL-15 superagonist antibody-cytokine fusion protein. It has two geographical segments: United states and Europe. Key revenue is generated from Europe.

Share on Social Networks: